MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dystonia in Cameroon: Clinical characteristic and treatment patterns

HD. Ewodo Touna, D. Gams Massi, M A. Magnerou, C. Kenmegne, E. Chokote, E. Gueumekane Bila, M. Tonga, D. Atsa Kouda, G. Nokam, Y. Mapoure Njankouo (Douala, Cameroon)

Meeting: 2025 International Congress

Keywords: Botulinum toxin: Clinical applications: dystonia

Category: Dystonia: Epidemiology, phenomenology, clinical assessment, rating scales

Objective: To describe the clinical characteristics and treatment patterns of dystonia in a cohort of Cameroonian patients.

Background: Dystonia is a complex and heterogeneous movement disorder with variable etiologies and manifestations. Despite its significant burden, dystonia remains understudied in many African countries, including Cameroon.

Method: We conducted a retrospective study of 35 patients with dystonia who were evaluated at six hospitals in Yaoundé and Douala, Cameroon, between October 2024 and March 2025. Patients’ demographic and clinical data were collected using a standardized questionnaire.

Results: RESULTS

 The mean age of the patients was 45.77 ± 18.62 years, and 60% were female. Focal dystonias were the most common subtype (82.86%), with writer’s cramp being the most frequent (22.86%). Segmental and generalized dystonias accounted for 8.57% and 8.57% of cases, respectively. Botulinum toxin injections were administered to 42.86% of patients.

Conclusion: CONCLUSION

Our results suggest that focal dystonias, particularly writer’s cramp, are the most common forms of Dystonia in Cameroon. However, access to effective treatments, such as botulinum toxin injection s remind limited

To cite this abstract in AMA style:

HD. Ewodo Touna, D. Gams Massi, M A. Magnerou, C. Kenmegne, E. Chokote, E. Gueumekane Bila, M. Tonga, D. Atsa Kouda, G. Nokam, Y. Mapoure Njankouo. Dystonia in Cameroon: Clinical characteristic and treatment patterns [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/dystonia-in-cameroon-clinical-characteristic-and-treatment-patterns/. Accessed June 6, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dystonia-in-cameroon-clinical-characteristic-and-treatment-patterns/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley